Department of Pathology Microbiology and Immunology Archive — Page 7 of 30
-
March 30, 2023
NIH grant launches C. diff vaccine research initiative
Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV. -
March 23, 2023
Mathers Foundation award supports study of bacterial physiology
Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases. -
March 23, 2023
E. coli uses serine to abide acidity
Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies. -
February 20, 2023
Probing hellbender health
Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights. -
February 2, 2023
Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections
-
January 20, 2023
Study reveals new genetic disorder that causes susceptibility to opportunistic infections
An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. -
January 13, 2023
Study identifies potential new approach for treating lupus
A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.